Great Point Partners LLC Repare Therapeutics Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$19.66 - $28.11 $1.83 Million - $2.62 Million
-93,137 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$25.71 - $35.24 $8.82 Million - $12.1 Million
-342,952 Reduced 78.64%
93,137 $2.44 Million
Q2 2021

Aug 16, 2021
BUY
$30.1 - $34.85 $13.1 Million - $15.2 Million
436,089 New
436,089 $13.6 Million

Others Institutions Holding RPTX

# of Institutions
62
Shares Held
35.4M
Call Options Held
50K
Put Options Held
300
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $125M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email